HZNP logo

HZNP Return On Equity

Annual ROE

10.70%
-1.59%-12.94%

December 31, 2022

Summary

Performance

1-Year Change

-12.94%

3-Year Change

-68.48%

5-Year Change

+134.62%

15-Year Change

+134.62%

HZNP ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

645.26%
HZNP annual return on equity is currently -98.34% below its historical high of 645.26%

3-Year Low

10.70%
HZNP annual return on equity is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
HZNP previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
HZNP next annual earnings announcement has not yet been scheduled

OtherHZNPprofitabilitymetrics:

Annual Revenue

$3.63 B
HZNP annual revenue is $3.63 billion

Annual Net Income

$521.48 M
HZNP annual net profit is $521.48 million

Annual EPS

$2.22
HZNP annual earnings per share is $2.22

Annual ROA

5.86%
HZNP annual return on assets is 5.86%

Quarterly ROE

8.60%
+1.15%+15.44%

June 30, 2023

Summary

Performance

3-Month Change

+15.44%

1-Year Change

-48.38%

3-Year Change

-67.39%

5-Year Change

+136.58%

HZNP Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

1072.00%
HZNP quarterly return on equity is currently -99.20% below its historical high of 1072.00%

3-Year Low

7.45%
HZNP quarterly return on equity is currently +15.44% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
HZNP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
HZNP next earnings announcement has not yet been scheduled

OtherHZNPprofitabilitymetrics:

Quarterly Revenue

$944.96 M
HZNP quarterly revenue is $944.96 million

Quarterly Net Income

$127.07 M
HZNP quarterly net profit is $127.07 million

Quarterly EPS

$0.54
HZNP quarterly earnings per share is $0.54

Quarterly ROA

4.84%
HZNP quarterly return on assets is 4.84%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

10.70%
HZNP annual return on equity is 10.70%

Annual Net Income

$521.48 M
HZNP annual net profit is $521.48 million

Annual Shareholders Equity

$5.07 B
HZNP annual stockholders equity is $5.07 billion

HZNP ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.9%-48.4%
3 y3 years-68.5%-67.4%
5 y5 years+134.6%+136.6%

HZNP ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-12.9%at low-56.4%-13.4%
5 y5-year-68.5%at low-76.1%-13.4%
alltimeall time-98.3%-4995.1%-99.2%-5542.3%

Horizon Therapeutics Public Limited ROE History

DateAnnualQuarterly
Jun 2023
-
8.60%(+15.4%)
Mar 2023
-
7.45%(-29.8%)
Dec 2022
10.70%(-12.9%)
10.62%(-11.5%)
Sep 2022
-
12.00%(-28.0%)
Jun 2022
-
16.66%(-15.5%)
Mar 2022
-
19.71%(+55.4%)
Dec 2021
12.29%(-2.1%)
12.68%(-7.2%)
Sep 2021
-
13.66%(-4.5%)
Jun 2021
-
14.30%(+65.7%)
Mar 2021
-
8.63%(-35.5%)
Dec 2020
12.55%(-63.0%)
13.39%(-59.1%)
Sep 2020
-
32.76%(+24.2%)
Jun 2020
-
26.37%(-20.3%)
Mar 2020
-
33.07%(-8.2%)
Dec 2019
33.95%(-1070.0%)
36.01%(+488.4%)
Sep 2019
-
6.12%(-24.4%)
Jun 2019
-
8.10%(+11.6%)
Mar 2019
-
7.26%(-282.9%)
Dec 2018
-3.50%(-88.7%)
-3.97%(-70.8%)
Sep 2018
-
-13.59%(-42.2%)
Jun 2018
-
-23.51%(-41.3%)
Mar 2018
-
-40.05%(+25.8%)
Dec 2017
-30.91%(+140.5%)
-31.83%(-24.4%)
Sep 2017
-
-42.09%(+19.9%)
Jun 2017
-
-35.11%(+115.3%)
Mar 2017
-
-16.31%(+29.4%)
Dec 2016
-12.85%
-12.60%(+1240.4%)
Sep 2016
-
-0.94%(+291.7%)
DateAnnualQuarterly
Jun 2016
-
-0.24%(-120.3%)
Mar 2016
-
1.18%(-69.8%)
Dec 2015
4.27%(-104.0%)
3.91%(-304.7%)
Sep 2015
-
-1.91%(-32.7%)
Jun 2015
-
-2.84%(-88.4%)
Mar 2015
-
-24.57%(-84.6%)
Dec 2014
-107.35%(-79.5%)
-159.17%(-66.0%)
Sep 2014
-
-468.04%(-143.7%)
Jun 2014
-
1072.00%(+11.1%)
Mar 2014
-
964.61%(-464.1%)
Dec 2013
-523.78%(+353.1%)
-264.96%(+245.1%)
Sep 2013
-
-76.78%(-16.3%)
Jun 2013
-
-91.68%(-2.6%)
Mar 2013
-
-94.11%(-10.0%)
Dec 2012
-115.60%(-27.0%)
-104.52%(-34.3%)
Sep 2012
-
-159.18%(-9.1%)
Jun 2012
-
-175.04%(+19.2%)
Mar 2012
-
-146.89%(+18.1%)
Dec 2011
-158.45%(+174.8%)
-124.35%(+156.7%)
Sep 2011
-
-48.45%(+8.9%)
Jun 2011
-
-44.50%(+36.1%)
Mar 2011
-
-32.70%(-5.4%)
Dec 2010
-57.66%(-108.9%)
-34.55%(-4.4%)
Sep 2010
-
-36.13%(+8.4%)
Jun 2010
-
-33.33%(-109.3%)
Mar 2010
-
358.07%(-44.5%)
Dec 2009
645.26%(+95.5%)
645.26%
Dec 2008
330.01%
-

FAQ

  • What is Horizon Therapeutics Public Limited annual return on equity?
  • What is the all time high annual ROE for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited annual ROE year-on-year change?
  • What is Horizon Therapeutics Public Limited quarterly return on equity?
  • What is the all time high quarterly ROE for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited quarterly ROE year-on-year change?

What is Horizon Therapeutics Public Limited annual return on equity?

The current annual ROE of HZNP is 10.70%

What is the all time high annual ROE for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high annual return on equity is 645.26%

What is Horizon Therapeutics Public Limited annual ROE year-on-year change?

Over the past year, HZNP annual return on equity has changed by -1.59% (-12.94%)

What is Horizon Therapeutics Public Limited quarterly return on equity?

The current quarterly ROE of HZNP is 8.60%

What is the all time high quarterly ROE for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high quarterly return on equity is 1072.00%

What is Horizon Therapeutics Public Limited quarterly ROE year-on-year change?

Over the past year, HZNP quarterly return on equity has changed by -8.06% (-48.38%)